[Pharmacodynamic properties of phosphorus organic acid derivatives. II].
D000143:Acids / Q000494:pharmacology*; D000777:Anesthetics / Q000494:pharmacology; D000818:Animals; D000890:Anti-Infective Agents / Q000494:pharmacology; D000924:Anticholesteremic Agents / Q000494:pharmacology; D000927:Anticonvulsants / Q000494:pharmacology; D000935:Antifungal Agents / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000494:pharmacology; D000970:Antineoplastic Agents; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004950:Esterases / Q000037:antagonists & inhibitors; D005123:Eye / Q000187:drug effects; D006728:Hormones / Q000494:pharmacology; D006801:Humans; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D007410:Intestinal Diseases / Q000188:drug therapy; D008055:Lipids / Q000097:blood; D008099:Liver / Q000187:drug effects; D009132:Muscles / Q000494:pharmacology; D009294:Narcotics / Q000494:pharmacology; D009417:Nerve Tissue / Q000187:drug effects; D009422:Nervous System Diseases / Q000188:drug therapy; D010120:Oxytocics / Q000494:pharmacology; D010758:Phosphorus / Q000378:metabolism / Q000494:pharmacology*; D011837:Radiation-Protective Agents / Q000494:pharmacology; D011838:Radiation-Sensitizing Agents / Q000494:pharmacology; D013438:Sulfhydryl Compounds / Q000494:pharmacology; D014511:Uremia / Q000188:drug therapy; D014815:Vitamins / Q000494:pharmacology
D000143:Acids; D000777:Anesthetics; D000890:Anti-Infective Agents; D000924:Anticholesteremic Agents; D000927:Anticonvulsants; D000935:Antifungal Agents; D000959:Antihypertensive Agents; D000970:Antineoplastic Agents; D002800:Cholinesterase Inhibitors; D006728:Hormones; D006993:Hypnotics and Sedatives; D008055:Lipids; D009294:Narcotics; D010120:Oxytocics; D011837:Radiation-Protective Agents; D011838:Radiation-Sensitizing Agents; D013438:Sulfhydryl Compounds; D014815:Vitamins; D010758:Phosphorus; D004950:Esterases
Propriétés pharmacodynamiques des dérivés organiques des acides du phosphore. II.